Livforsakringsbolaget Skandia’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Hold |
|
|||||
|
2025
Q1 | $270K | Hold |
|
|||||
|
2024
Q4 | $235K | Hold |
|
|||||
|
2024
Q3 | $275K | Buy |
|
|||||
|
2024
Q2 | $48.6K | Hold |
|
|||||
|
2024
Q1 | $29.9K | Hold |
|
|||||
|
2023
Q4 | $38.3K | Hold |
|
|||||
|
2023
Q3 | $35.4K | Hold |
|
|||||
|
2023
Q2 | $38K | Hold |
|
|||||
|
2023
Q1 | $40.1K | Hold |
|
|||||
|
2022
Q4 | $47.5K | Hold |
|
|||||
|
2022
Q3 | $40K | Sell |
|
|||||
|
2022
Q2 | $117K | Sell |
|
|||||
|
2022
Q1 | $310K | Hold |
|
|||||
|
2021
Q4 | $322K | Hold |
|
|||||
|
2021
Q3 | $359K | Hold |
|
|||||
|
2021
Q2 | $322K | Buy |
|
|||||
|
2021
Q1 | $184K | Hold |
|
|||||
|
2020
Q4 | $169K | Hold |
|
|||||
|
2020
Q3 | $189K | Hold |
|
|||||
|
2020
Q2 | $193K | Hold |
|
|||||
|
2020
Q1 | $142K | Hold |
|
|||||
|
2019
Q4 | $150K | Buy |
|
|||||
|
2019
Q3 | $64K | Hold |
|
|||||
|
2019
Q2 | $58K | Hold |
|
|||||
|
2019
Q1 | $75K | Hold |
|
|||||
|
2018
Q4 | $58K | Hold |
|
|||||
|
2018
Q3 | $70K | Sell |
|
|||||
|
2018
Q2 | $197K | Hold |
|
|||||
|
2018
Q1 | $238K | Buy |
|
|||||
|
2017
Q4 | $165K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $294K | Buy |
|
|||||
|
2016
Q2 | $405K | Hold |
|
|||||
|
2016
Q1 | $458K | Hold |
|
|||||
|
2015
Q4 | $687K | Hold |
|
|||||
|
2015
Q3 | $587K | Hold |
|
|||||
|
2015
Q2 | $875K | Buy |
|